Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Traditional Chinese Medicine Co., Ltd., a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., is a leading enterprise in the traditional Chinese medicine (TCM) industry. The company operates a comprehensive business model encompassing the cultivation of medicinal herbs, the processing of decoction pieces, and the manufacturing of finished TCM products. It holds several prestigious China Time-honored Brand titles, including Lei Yun Shang and Shen Xiang. The company is dedicated to the modernization of TCM, utilizing advanced R&D to validate traditional formulas for indications such as cardiovascular and respiratory health. With a robust distribution network and a commitment to quality, it remains a dominant player in the Chinese domestic market and is expanding its international footprint. Its product portfolio includes well-known treatments like the Shexiang Baoxin Pill, which is widely used for coronary heart disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TCM Shanghai.